tradingkey.logo
tradingkey.logo
Pesquisar

Anika Therapeutics Inc

ANIK
Adicionar à lista de desejos
14.620USD
-0.110-0.75%
Fechamento 06/25, 16:00ETCotações atrasadas em 15 min
194.53MValor de mercado
PerdaP/L TTM

Mais detalhes de Anika Therapeutics Inc Empresa

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Informações de Anika Therapeutics Inc

Código da empresaANIK
Nome da EmpresaAnika Therapeutics Inc
Data de listagemMay 16, 1985
CEOBlanchard (Cheryl Renee)
Número de funcionários288
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 16
Endereço32 Wiggins Ave
CidadeBEDFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01730-2315
Telefone17814579000
Sitehttps://anika.com/
Código da empresaANIK
Data de listagemMay 16, 1985
CEOBlanchard (Cheryl Renee)

Executivos da empresa Anika Therapeutics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
42.57K
+6.40%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
42.57K
+6.40%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Anika Therapeutics Inc?

Os cinco principais acionistas de Anika Therapeutics Inc são: Mr. Stephen D. (Steve) Griffin

Quantas instituições possuem ações da Anika Therapeutics Inc (ANIK)?

Em 2026Q1, 264 instituições possuíam ações da Anika Therapeutics Inc, com valor de mercado aproximado de 12.85M, representando 96.55% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1611291.00.

Qual é a maior fonte de receita da Anika Therapeutics Inc?

Em 2026Q1, o segmento de negócios OEM Channel gerou a maior receita para Anika Therapeutics Inc, totalizando 64.41M e representando 57.09% da receita total.
KeyAI